Helmut Gadner - Concepedia

Author

Helmut Gadner

Also Known As

D. Schuler, Gadner, Helmut, H GADNER, H Gadner, H. GADNER, H. Gadner, H. Gadner, H.G. Gadner, HELMUT GADNER, Helmut Gadner

555

Publications

31.6K

Citations

H-Index

190

Concepts

All Affiliations

St Anna Children's Hospital University of Vienna Medizinische Hochschule Hannover Medical University of Vienna Community College of Rhode Island

About

Helmut Gadner is an author at St Anna Children's Hospital specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	137	9.8K
2	Health Sciences	18	25	2.1K
3	Education	1	1	47
4	Engineering	1	1	17
5	Natural Sciences	1	1	19

Helmut Gadner

296

Publications

27.9K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group Simon Cotterill, S. Ahrens, Michael Paulussen, Journal of Clinical Oncology	2000	1K
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Leo Kager, A. Zoubek, Ulrike Pötschger, Journal of Clinical Oncology	2003	939
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol Helena Trottestam, AnnaCarin Horne, Maurizio Aricò, Blood	2011	662
MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration Inge M. Ambros, Peter F. Ambros, Sabine Strehl, Cancer Specific Chromosome AberrationTumoral PathologyY ChromosomesMalignant DiseaseMic2 Gene	1991	655
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Martin Schrappe, Alfred Reiter, Wolfgang Ludwig, PubMed	2000	609
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 Anja Möricke, Alfred Reiter, Martin Zimmermann, Blood	2008	601
HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis Jan‐Inge Henter, Maurizio Aricò, R. Maarten Egeler, Medical and Pediatric Oncology Lymphoid NeoplasiaHematologyCell DeathPathologyTreatment Protocol	1997	528
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000 Anja Möricke, M Zimmermann, Alfred Reiter, Leukemia Hematological MalignancyLymphoid NeoplasiaAll-bfm Study GroupOncologyPediatric Hematology	2009	520
A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis Helmut Gadner, Nicole Grois, Maurizio Aricò, The Journal of Pediatrics HistopathologyHematologyPathologyRandomized TrialMedicine	2001	476
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis Helmut Gadner, Milen Minkov, Nicole Grois, Blood	2013	441

Page 1